1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci 1991; 49: 1593-1601.
1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci 1991; 49: 1593-1601.
2
0031475064
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake
Bernard BF, Krenning EP, Breeman WA et al. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med 1997; 38: 1929-1933.
Between the Scylla and Charybdis of peptide radionuclide therapy: Hitting the tumor and saving the kidney
Boerman OC, Oyen WJ, Corstens FH. Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney. Eur J Nucl Med 2001; 28: 1447-1449.
Radiolabelled peptides for tumour therapy: Current status and future directions. Plenary lecture at the EANM 2002
De Jong M, Kwekkeboom D, Valkema R et al. Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002. Eur J Nucl Med Mol Imaging 2003; 30: 463-469.
In vivo radionuclide uptake quantification using a multipinhole SPECT system to predict renal function in small animals
Forrer F, Valkema R, Bernard B et al. In vivo radionuclide uptake quantification using a multipinhole SPECT system to predict renal function in small animals. Eur J Nucl Med Mol Imaging 2006; 33: 1214-1217.
86Y-DOTA(0)-d-Phe(1)- Tyr(3)-octreotide (SMT487) - a phase 1 clinical study: Pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion
86Y-DOTA(0)-d-Phe(1)- Tyr(3)-octreotide (SMT487) - a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion. Eur J Nucl Med Mol Imaging 2003; 30: 510-518.
Overview of results of peptide receptor radionuclide therapy with 3 radiolabelled somatostatin analogs
Kwekkeboom DJ, Mueller-Brand J, Paganelli G et al. Overview of results of peptide receptor radionuclide therapy with 3 radiolabelled somatostatin analogs. J Nucl Med 2005; 46: 62S-66S.
The effects of arginine, dextran and Haemaccel infusions on urinary albumin, beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase
O'Reilly DS, Parry ES, Whicher JT. The effects of arginine, dextran and Haemaccel infusions on urinary albumin, beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase. Clin Chim Acta 1986; 155: 319-327.
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine
Rolleman EJ, Valkema R, De Jong M et al. Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine. Eur J Nucl Med Mol Imaging 2003; 30: 9-15.
Inhibition of kidney uptake of radiolabelled somatostatin analogs: Amino acids or Gelofusine?
Rolleman EJ, de Jong M, Valkema R et al. Inhibition of kidney uptake of radiolabelled somatostatin analogs: amino acids or Gelofusine? J Nucl Med 2006; 47: 1730-1731.
The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption
Ten Dam MA, Branten AJ, Klasen IS et al. The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption. J Crit Care 2001; 16: 115-120.
Reply: Inhibition of kidney uptake of radiolabelled somatostatin analogs: amino acids or Gelofusine?
Van Eerd JE, Vegt E, Wetzels J et al. Reply: inhibition of kidney uptake of radiolabelled somatostatin analogs: amino acids or Gelofusine? J Nucl Med 2006; 47: 1731.
Renal uptake of radiolabelled octreotide in human subjects is efficiently inhibited by succinylated gelatin
Vegt E, Wetzels JF, Russel FG et al. Renal uptake of radiolabelled octreotide in human subjects is efficiently inhibited by succinylated gelatin. J Nucl Med 2006; 47: 432-436.
